Biotech · Private company · Englewood Cliffs, NJ, US
Immunogenic Cancer Engineering Therapeutics LLC
Track this companyFree. Adds Immunogenic Cancer Engineering Therapeutics LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Development of MCL 1-Targeting Antibody–Drug Conjugates for Cancer TherapyFiscal year 2026 · $412.4KNIH RePORTER 1R41CA314855-01 · fetched Nov 12, 2026